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Background: Metastases to the pituitary gland are rare events, and usually indicate widespread malignant disease.
The lung and the breast are the most common sites of primary tumors that metastasize to the pituitary gland.
Metastases are more frequent in older patients and the most common symptoms at presentation are diabetes
insipidus and visual alterations.
Case presentation: 72-year-old white woman was treated for a breast carcinoma with right superoexternal
quadrantectomy, radiotherapy, and hormone therapy. Twelve years later, the patient presented with bone pain,
bilateral progressive visual decline, and onset of hypopituitarism. A diagnosis of secondary bone involvement and
pituitary metastasis was made.
Conclusion: This was an unusual disease course, and stresses the importance of intensive follow-up in patients
with breast cancer even many years after the initial diagnosis This case emphasizes that diagnosis can be
difficultand controversial when relapse occurs at uncommon sites.
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Pituitary metastases are an uncommon complication of
cancer, representing only 1% of the pituitary lesions [1,2]
and 0.14% to 28% of all brain metastases in reported aut-
opsy series [3,4]. They are often related to primary
breast (20% to 30% of cases) or lung cancers (30% to
50% of cases), with other sites of primary tumors being
reported less often [1,2,5,6]. Pituitary metastases are
symptomatic in only 8% of cases [1,2], with the most im-
portant signs being diabetes insipidus and anterior pitu-
itary gland dysfunction. The tumor mass may also cause
headache, visual alterations, and ophthalmoplegia
[1,2,5,6]. No gender predominance has been reported
[2]. At diagnosis, most patients are elderly, and have
widespread disease with multiple sites of implantation
[7,8]. Pituitary metastases may also be the first presenta-
tion of an occult primary cancer or may be the only site
of metastasis [9-11]. They very rarely occur in early* Correspondence: gianpaolo.spinelli@uniroma1.it
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logical and clinical signs make it difficult to distinguish
these tumors from other more common benign pituitary
lesions [9,13]. We present a case of late recurrence of
breast cancer presenting asbone metastases and a pituit-
ary metastatic mass.Case presentation
A 72 year-old woman underwent a superoexternal quad-
rantectomy with axillary lymph-node dissection for an
infiltrating ductal carcinoma of the right breast (not
otherwise specified variant, G1, pT1c, pN0, estrogen
receptor-positive, progesterone receptor-positive), and
was treated with radiotherapy and tamoxifen for 5 years.
There were no signs of recurrence for almost 12 years,
at which point gait disturbances appeared.
Total body computed tomography showed numerous
hyperdense lesions in many vertebral bodies and costal
arches. A bone scan was performed, but the lesions were
not confirmed as metastases. Despite the negative results
for bone scan and tumor markers, a bone biopsy was
taken, and the results of this examination led to aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 T1-weighted magnetic resonance imaging scan of the brain. (A) Coronal image of pituitary metastasis causing compression of the
optic chiasm; (B) detail of optic chiasm compression.
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treatment with letrozole.
Around 4 months later, the patient began experien-
cing visual disturbances. Magnetic resonance imaging
(MRI) of the pituitary region showed a sellar mass, ap-
proximately 11 mm in diameter, compressing the optic
chiasm. The Lesion was compatible with pituitary ad-
enoma, which was confirmed by endocrinologica find-
ings documenting the presence of hypopituitarism.
Laboratory test results showed that the patients thy-
roid function, gonadotropin and serum prolactin levels
were normal, but there was hyponatremia and hyper-
kalemia and reduced levels of adrenocorticotropic hor-
mone and cortisol. The patient was started on steroid
therapy.
Three months later, owing to progressive deterioration
of the visual disturbances (bi-temporal hemianopsia),
gadolinium-enhanced MRI of the brain was carried out,
which showed a large heterogeneous mass, which
appeared intensely opaque after contrast. Moreover, the
mass had a supra-sellar extension and was infiltrating
the optic chiasm (Figure 1, Figure 2). Despite theFigure 2 T1-weighted magnetic resonance imaging. (A) Pre-contrast m
pituitary metastasis.probable metastatic nature of the lesion, the patient
underwent a trans-sphenoidal surgery of the tumor and
a subtotal resection was achieved. The histological find-
ings identified the mass as a malignant neoplasm com-
patible with metastatic breast cancer and specifically a
poorly differentiated adenocarcinoma (Figure 3). The
immunohistochemistry results showed that the cells
were positive for estrogen and progestin receptor and
negative for ErbB-2, Unfortunately, the surgery did not
improve the patient’s visual disturbances, and no other
treatments were performed because of the rapid deteri-
oration in her clinical condition.
Discussion
Breast cancer is one of the most common types of can-
cer, and recurrence within 5 years after diagnosis is fre-
quent; however, rates of recurrence and disease relapse
have greatly improved over the past 10 years is not com-
mon. In general, the most important sites for metastasis
are bone, liver, and lung [14].
The pituitary gland is a rare site for metastasis for all
neoplasm (metastases make up less than 1% of pituitaryid-sagittal image of pituitary metastasis; (B) post-contrast detail of
Figure 3 Microscopic examination. Neoplasm composed of
atypical cells with hyperchromatic and anaplastic nuclei.
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tient shows a rare pattern of breast cancer metastasis.
However, cancers of almost all tissues can metastasize to
the pituitary gland.
The lung and breast are the most important loca-
tions for the primary tumor localizations in men and
women, respectively, but in about 5% of cases the pri-
mary cancer remains unknown [1,2,5-7]. Identification
of metastases is more common in elderly patients, and
in many cases is suggestive of the presence of dissemi-
nated disease and carries a poor prognosis[7,8]. The
hematogenous spread (direct to the pituitary paren-
chyma or diaphragm sellae through the portal vessels)
is the most important mechanism for development of
these metastases. Alternative hypotheses for spread are
extension from an adjacent bone metastasis or a men-
ingeal spread through the supra-sellar cistern [7,10].
The posterior lobe is more affected than the anterior
lobe, mainly because of the lack of a direct arterial
blood supply to the anterior lobe and because there is
a larger area of contact between the posterior lobe and
the adjacent dura madre [3,15]. For this reason, the
most common sign of this metastatic involvement is
diabetes insipidus [1,2,4,13], whereas hypoadrenalism
and bilateral hemianopsia, as seen in our patient, are
less common [1,2].
The case shows that the metastatic lesions of pituitary
gland can mimic the signs and symptoms of pituitary
macroadenoma, leading to a delay in diagnosis of several
months. The rarity of this event made diagnosis and the
subsequent choice of therapeutic approach difficult.Conclusion
We report this rare clinical case is primarily to
emphasize the importance of careful follow-up, espe-
cially in breast cancer. The correct differential diagnosis
between benign and malignant lesions in the pituitary
region is essential for effective treatment.
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